Society for Neuroscience Abstracts, 29, 757.11 (2003)

 

Stimulant and antidepressant-like effects of novel arylketones.

 

Nicholas V. Cozzi and Kevin F. Foley

 

Department of
Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834


Abstract

The antidepressant drug bupropion and the psychostimulant drug methcathinone belong to a chemical class known as aminopropiophenones. Differences in the psychoactivity of these drugs result from small changes to their chemical skeleton, but structure-activity relationships are poorly defined. To investigate this, we synthesized analogs of bupropion and methcathinone and tested the new compounds for psychoactivity. The synthesized compounds are 2-methylamino-1-(3-bromophenyl)propan-1-one (3-BMAP), 2-methylamino-1-(4-bromophenyl)propan-1-one (4-BMAP), 2-iso-propylamino-1-phenylpropan-1-one (i-PAP), and 2-tert-butylamino-1-phenylpropan-1-one (t-BAP). Bupropion, methcathinone, desipramine, and the newly synthesized compounds were administered to rats for behavioral testing. We used the Porsolt swim test to assess antidepressant-like activity and we monitored locomotor activity to test for stimulant effects. All of the compounds displayed antidepressant-like effects in the swim test. Some compounds, including bupropion, increased locomotor activity at moderate-to-high doses but 4-BMAP did not increase locomotor activity, even at the highest dose tested. The data indicate that phenyl ring substitution or branched alkylamines can shift the psychopharmacology of aminopropiophenones from stimulant to antidepressant-like activity.


Return to Publications
Return to Synaptic Shenanigans


This page last modified on November 3, 2003